COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 1330: Articles 13291-13300  | Next

Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021 reflect community transmission: prospective cohort study Ciao Corona
Ulyte, A., Radtke, T., Abela, I. A., Haile, S. R., Ammann, P., Berger, C., Trkola, A., Fehr, J., Puhan, M. A., Kriemler, S.
10.1101/2021.07.19.21260644 — Posted: 2021-07-19
Vaccination is Australia's most important COVID-19 public health action, even though herd immunity is unlikely
McBryde, E. S., Meehan, M. T., Sziklay, J., Adekunle, A., Kuddus, A., Ogunlade, S., Jayasundara, P., Ragonnet, R., Trauer, J. M., Cope, R. C.
10.1101/2021.07.16.21260642 — Posted: 2021-07-19
ABO and Rh blood groups, demographics, and comorbidities in COVID-19 related deaths: a retrospective study in Split-Dalmatia County, Croatia
Brdar, I., Jerkovic, I., Basic, Z., Kunac, N., Anđelinovic, D., Bezic, J., Kruzic, I., Vuko, A., Anđelinovic, S.
10.1101/2021.07.16.21260630 — Posted: 2021-07-19
SARS-CoV-2 infection in fully vaccinated individuals of old age strongly boosters the humoral immune response
Müller, L., Andree, M., Ostermann, P. N., Jazmati, N., Flüh, G., Fischer, J. C., Bölke, E., Wisplinghoff, H., Schaal, H., Drexler, I., Walker, A., Adams, O., Timm, J.
10.1101/2021.07.19.21260563 — Posted: 2021-07-19
Social determinants of health exacerbate disparities in COVID-19 illness severity and lasting symptom complaints
Thomason, M., Hendrix, C. L., Werchan, D., Brito, N. H.
10.1101/2021.07.16.21260638 — Posted: 2021-07-19
Low seropositivity and sub-optimal neutralisation rates in patients fully vaccinated against COVID-19 with B cell malignancies.
Fox, T. A., Kirkwood, A. A., Enfield, L., O'Reilly, M., Arulogun, S., D'Sa, S., O'Nions, J., Kavi, J., Vitsaras, E., Townsend, W., Burns, S. O., Gohil, S. H., Cwynarski, K., Thomson, K. J., Noursadeghi, M., Heyderman, R. S., Rampling, T., Ardeshna, K. M., McCoy, L. E., Morris, E. C.
10.1101/2021.07.19.21260762 — Posted: 2021-07-19
Prevalence of anti-platelet factor4/polyanionic antibodies after COVID-19 vaccination with ChAdOx1 nCoV-19 and CoronaVac in Thais
Noikongdee, P., Police, P., Phojanasenee, T., Chantrathammachart, P., Niparuck, P., Puavilai, T., Phuphuakrat, A., Angchaisuksiri, P., Boonyawat, K.
10.1101/2021.07.15.21260622 — Posted: 2021-07-19
Identifying Louisiana Communities at the Crossroads of Environmental and Social Vulnerability, COVID-19, and Asthma
Bakshi, A., Van Doren, A., Maser, C., Aubin, K., Stewart, C., Soileau, S., Friedman, K., Williams, A.
10.1101/2021.07.19.21257742 — Posted: 2021-07-19
Association between willingness to receive the COVID-19 vaccine and sources of health information among Japanese workers: a cohort study
Hiraoka, K., Nagata, T., MORI, T., Ando, H., Hino, A., Tateishi, S., Tsuji, M., Matsuda, S., Fujino, Y.
10.1101/2021.07.15.21260609 — Posted: 2021-07-19
COVID-19 Chest X-Ray Image Classification Using Deep Learning
Dey, S., Bacellar, G. C., Chandrappa, M. B., Kulkarni, R.
10.1101/2021.07.15.21260605 — Posted: 2021-07-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).